Gene · 6555
Papers1,442
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,442
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Gut-to-bile transfer of microbially amidated minor bile acids in patients with hepatopancreatobiliary disorders. | Hepatology | 2026 | 40550113 | PubTator, text mining | PubMed |
| Case Report: Sustained biochemical remission following early initiation of odevixibat in an infant with monoallelic ABCB11 mutation and histologically confirmed PFIC2. | Front Pediatr | 2025 | 41395309 | PubTator, text mining | PubMed |
| Editorial: Helminthosis: immuno-pathology and anthelmintic vaccines. | Front Immunol | 2025 | 41333461 | PubTator, text mining | PubMed |
| Enantiomeric Resolution of Odevixibat via Immobilized Polysaccharide Columns: Impact of NP, RP, and PO Modes on LC-MS-Compatible Method Design. | Chirality | 2025 | 41328567 | PubTator, text mining | PubMed |
| Elevated Serum Bile Acids Predict Poor Liver Outcomes in Children With Alagille Syndrome: Results From the GALA Study Group. | Liver Int | 2025 | 41250932 | PubTator, text mining | PubMed |
| Bile acids and apical sodium-dependent bile acid transporter impact per- and polyfluoroalkyl substances absorption: Evidence from in vivo and cross-sectional studies. | J Hazard Mater | 2025 | 41101165 | PubTator, text mining | PubMed |
| Elimination of CDX2 restricts intestinal hybrid differentiation signatures in stem cell-derived hepatocyte-like cells. | Stem Cell Res Ther | 2025 | 41057965 | PubTator, text mining | PubMed |
| Carrier cross-reactivities of the bile acid reabsorption inhibitors elobixibat, linerixibat, maralixibat, and odevixibat. | J Lipid Res | 2025 | 40998033 | PubTator, text mining | PubMed |
| Integrative genome-wide analysis unveils the genetic landscape of gallstone disease and highlights novel loci with therapeutic potential. | BMJ Open Gastroenterol | 2025 | 40953858 | PubTator, text mining | PubMed |
| Homozygosity for a variant in SLC10A2 and infancy onset severe fat-soluble vitamin deficiency due to bile acid malabsorption. | JPGN Rep | 2025 | 40814585 | PubTator, text mining | PubMed |
| The metabolic advantage of being young and male in obesity treatment outcomes in mice. | NPJ Metab Health Dis | 2025 | 40751023 | PubTator, text mining | PubMed |
| New hope in treating progressive familial intrahepatic cholestasis in children. | World J Hepatol | 2025 | 40747224 | PubTator, text mining | PubMed |
| Cholic acid as a treatment for cerebrotendinous xanthomatosis: a comprehensive review of safety and efficacy. | Orphanet J Rare Dis | 2025 | 40731019 | PubTator, text mining | PubMed |
| Effects of Proanthocyanidins on Growth Performance, Intestinal Inflammation and Barrier Function, and Bile Acid Metabolism-Related Genes in Weaned Piglets Challenged with Lipopolysaccharide. | Animals (Basel) | 2025 | 40646724 | PubTator, text mining | PubMed |
| Benefits and challenges to therapeutic targeting of bile acid circulation in cholestatic liver disease. | Hepatology | 2025 | 40601300 | PubTator, text mining | PubMed |
| Harnessing the apical sodium-dependent bile acid transporter for enhanced oral delivery of peptide drugs: mechanisms, strategies, and therapeutic potential. | Expert Opin Drug Deliv | 2025 | 40548518 | PubTator, text mining | PubMed |
| Enteronephrohepatic circulation of bile acids and therapeutic potential of systemic bile acid transporter inhibitors. | J Hepatol | 2025 | 40414504 | PubTator, text mining | PubMed |
| Fluorescent 4-Nitrobenzo-2-oxa-1,3-diazole-Coupled Bile Acids as Probe Substrates of Hepatic and Intestinal Bile Acid Transporters of the Solute Carrier Families SLC10 and SLCO. | J Med Chem | 2025 | 40380953 | PubTator, text mining | PubMed |
| ASBT governs neonatal bile acid homeostasis early in life despite its strong ileal repression. | Am J Physiol Gastrointest Liver Physiol | 2025 | 40380125 | PubTator, text mining | PubMed |
| Characterization of intestinal transporters in human ileal spheroid-derived differentiated cells for the prediction of intestinal drug absorption. | Drug Metab Dispos | 2025 | 40319556 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6555/papers?page=3